In vivo performance of time-controlled explosion system (TES) in GI physiology regulated dogs

International Journal of Pharmaceutics

Volumn 161, Issue 2, 1998, Pages 161-168

  Murata, Saburo ^a   Ueda, Satoshi ^a   Shimojo, Fumio ^a   Tokunaga, Yuji ^b   Hata, Takehisa ^b   Ohnishi, Norio ^a  

^a Fujisawa P   (Japan)

^b Fujisawa P   (Japan)

Author keywords

Diclofenac; Gastrointestinal transit; Time controlled explosion system (TES)

Indexed keywords

DICLOFENAC; ETHYL CELLULOSE; ETOCEL; HYDROXYPROPYLCELLULOSE; TALC; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOG; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG MANUFACTURE; DRUG RELEASE; DRUG SOLUBILITY; DRUG TARGETING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INTESTINE TRANSIT TIME; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STOMACH EMPTYING; TIMED DRUG RELEASE; ULTRAVIOLET SPECTROPHOTOMETRY; WATER CONTENT;

EID: 0032559618     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00347-5     Document Type: Article

References (13)

1. Aoyagi N., Ogata H., Kaniwa N., Koibuchi M., Shibazaki T., Ejima A., Tamaki N., Kamimura H., Katoguchi Y., Omi Y. Bioavailability of griseofulvin from tablets in beagle dogs and correlation with dissolution rate and bioavailability in humans. J. Pharm. Sci. 7:1982;1169-1172.
2. Davis S.S., Hardy J.G., Fare J.W. Transit of pharmaceutical dosage forms through the small intestine. Gut. 27:1986;886-892.
3. Dressman J.B. Comparison of canine and human gastrointestinal physiology. Pharm. Res. 3:1986;123-131.
4. Gleiten C.K., Antonin K.-H., Bieck P., Godbillon J., Schonleber W., Malchow H. Colonscopy in the investigation of drug absorption in healthy volunteers. Gastrointest. Endosc. 31:1985;71-73.
5. Hirtz J. The gastrointestinal absorption of drugs in man: A review of current contents and methods of investigation. Br. J. Clin. Pharmacol. 19:1985;77S-83.
6. Mizuta H., Kawazoe Y., Haga K., Ogawa K., Yokobe T. Determination of small intestinal transit time in beagle dogs using salicylazosulfapyridine. Yakugaku Zasshi. 109:1989;760-765.
7. Mizuta H., Kawazoe Y., Ogawa K. Gastrointestinal absorption of chlorothiazide: Evaluation of a method using salicylazosulfapyridine and acetaminophen as the maker compounds for determination of the gastrointestinal transit time in the dog. Chem. Pharm. Bull. 38:1990;2810-2813.
8. Narisawa S., Nagata M., Ito T., Yoshino H., Hirakawa Y., Noda K. Drug release behavior in gastrointestinal tract of beagle dogs from multiple unit type rate-controlled or time-controlled release preparations coated with insoluble polymer-based film. J. Control. Release. 33:1995;253-260.
9. Ogata H., Aoyagi N., Kaniwa N., Koibuchi M., Shibazaki T., Ejima A., Shimamoto T., Yashiki T., Ogawa Y., Uda Y., Nishida Y. Correlation of the bioavailability of diazopam from uncoated tablets in beagle dogs with its dissolution rate and bioavailability in humans. Int. J. Clin. Pharmacol. Ther. Toxicol. 20:1982;576-581.
10. Sagara K., Nagamatsu Y., Yamada I., Kawata M., Mizuta H., Ogawa K. Bioavailability study of commercial sustained-release preparations of diclofenac sodium in gastrointestinal physiology regulated dogs. Chem. Pharm. Bull. 40:1992;3303-3306.
11. Tsunoo M., Yoshimura K., Maruyama Y., Takahashi M., Oikawa T., Iwasa A., Kuraishi T., Nishimura T., Inoue M., Kokita T., Numata H. Pharmacokinetics of dichlofenac and its metabolites after oral single or multi administration of the sustained-release preparation (SR-318). Prog. Med. 9(Suppl. 2):1989;887-892.
12. Ueda S., Hata T., Asakura S., Yamaguchi H., Kotani M., Ueda Y. Development of a novel drug delivery system. Time-controlled Explosion System (TES). I. Concept and design. J. Drug Targeting. 2:1994;35-44.
13. Ueda S., Ibuki R., Kawamura A., Murata S., Takahashi T., Kimura S., Hata T. Development of a novel drug delivery system. Time-controlled Explosion System (TES). IV. In vivo drug release behavior. J. Drug Targeting. 2:1994;133-140.